Additionally, experimental results also revealed that expressions of LOX, LOXL1, LOXL2, and LOXL3 were higher in glioma cell lines (T98G and A172) at mRNA and protein levels compared with the normal astrocyte HEB. This evidence concerns the gene LOXL1 and central nervous system cancer.